| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Department of Biochemistry, Case Western Reserve University, Cleveland Ohio 44106 [R. N., G. Z., E. S.]; Department of Molecular Genetics, Biochemistry and Microbiology, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267 [R. N.]; National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, Maryland 21702 [P. S.]; and Department of Animal Science, University of Minnesota, St Paul, Minnesota 55108 [D. N. F.]
The ski oncogene encodes a transcription factor that induces both transformation and muscle differentiation in avian fibroblasts. The first 304 amino acids of chicken Ski, the transformation domain, are both necessary and sufficient to mediate these biological activities. Skis biological duality is mirrored by its transcriptional activities: it coactivates or corepresses transcription depending on its interactions with other transcription factors. Ski represses transcription through specific binding to GTCTAGAC (GTCT element) but it possesses a transferable repression activity that can function independently of this DNA element. In this study, we locate this repression domain to the NH2-terminal two-thirds and the GTCT binding region to the COOH-terminal one-third of Skis transformation domain. Mutations in the transformation domain of c-Ski reveal a strong correlation between GTCT-mediated transcriptional repression and the biological activities of transformation and myogenesis. We also show that a dimerization domain located at the COOH terminal end of the Ski protein increases its transforming activity and its binding to GTCTAGAC.
This article has been cited by other articles:
![]() |
N. Ueki and M. J. Hayman Direct Interaction of Ski with Either Smad3 or Smad4 Is Necessary and Sufficient for Ski-mediated Repression of Transforming Growth Factor-{beta} Signaling J. Biol. Chem., August 29, 2003; 278(35): 32489 - 32492. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Akiyoshi, H. Inoue, J.-i. Hanai, K. Kusanagi, N. Nemoto, K. Miyazono, and M. Kawabata c-Ski Acts as a Transcriptional Co-repressor in Transforming Growth Factor-beta Signaling through Interaction with Smads J. Biol. Chem., December 3, 1999; 274(49): 35269 - 35277. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. C. Mertani, T. Zhu, E. L. K. Goh, K.-O. Lee, G. Morel, and P. E. Lobie Autocrine Human Growth Hormone (hGH) Regulation of Human Mammary Carcinoma Cell Gene Expression. IDENTIFICATION OF CHOP AS A MEDIATOR OF hGH-STIMULATED HUMAN MAMMARY CARCINOMA CELL SURVIVAL J. Biol. Chem., June 8, 2001; 276(24): 21464 - 21475. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Xu, K. Angelis, D. Danielpour, M. M. Haddad, O. Bischof, J. Campisi, E. Stavnezer, and E. E. Medrano Ski acts as a co-repressor with Smad2 and Smad3 to regulate the response to type beta transforming growth factor PNAS, May 23, 2000; 97(11): 5924 - 5929. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |